日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial

在转移性去势抵抗性前列腺癌患者接受多西他赛和阿比特龙治疗后出现疾病进展的情况下，新型雄激素受体抑制剂氘代沙鲁胺的疗效：来自随机 III 期 HC-1119-04 试验的结果

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-026-02618-3
Wu, Junlong; Li, Xinghai; Gu, Chengyuan; Hua, Lixin; Liu, Ranlu; Li, Jun; Qiu, Mingxing; Guo, Jianming; Dong, Haiying; Ji, Zhigang; Xie, Liping; Zhu, Shaoxing; Zhang, Xuhui; Chen, Peng; Jiang, Shusuan; Sun, Zhongquan; Xu, Danfeng; Chen, Hui; Shi, Benkang; Wang, Yujie; Pu, Jinxian; Perabo, Frank; Chen, Yuanwei; Ye, Dingwei
肿瘤
肿瘤免疫
信号转导
前列腺癌
免疫/内分泌
发表日期：2026
文献求助 收藏

Implantable soft bladder-machine interface for neurogenic bladder dysfunction

用于治疗神经源性膀胱功能障碍的可植入式软性膀胱-机器接口

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-70680-0
Li, Hanfei; Wang, Shuai; Yu, Qianhengyuan; Zhao, Hang; Tang, Zhuochao; Lv, Linchen; Han, Fei; Yang, Ruofan; Zhao, Yang; Fu, Zhuojia; Shi, Benkang; Li, Guanglin; Wang, Changxian; Zhang, Jie; Song, Kaikai; Li, Yan; Liu, Zhiyuan
发表日期：2026
文献求助 收藏

Intravesical instillation of pirfenidone/polydopamine nanoparticles for managing neurogenic bladder post-spinal cord injury by alleviating bladder inflammation and fibrosis.

通过膀胱内灌注吡非尼酮/聚多巴胺纳米颗粒治疗脊髓损伤后神经源性膀胱，减轻膀胱炎症和纤维化。

期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-026-04025-w
Zhang Jizheng, Li Hui, Zhang Lekai, Lv Linchen, Zang Maolin, Wang Xinyv, Wang Shuai, Chen Lipeng, Yang Zizhuo, Yang Liang, Zhao Jianyou, Gao Xindong, Guo Dongyue, Shi Benkang, Zhang Zhiyue, Li Yan
炎症/感染
脊髓损伤
炎症
神经科学
发表日期：2026
文献求助 收藏

PRDM1 restricts bladder cancer progression and enhances chemosensitivity by suppressing OTUD6A-mediated deubiquitination of CDC6.

PRDM1 通过抑制 OTUD6A 介导的 CDC6 去泛素化来限制膀胱癌的进展并增强化疗敏感性。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-026-08498-3
Cui Jianfeng, Chen Shouzhen, Liu Xiaochen, Jiang Xuewen, Cheng Guangzhou, Liu Zhifeng, Zhao Hui, Zhu Yaofeng, Shi Benkang, Zou Yongxin
膀胱癌
肿瘤
CDC6
PRDM1
泛素化
发表日期：2026
文献求助 收藏

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1-Mediated Transactivation of CD47.

SMYD3 通过 SREBP1 介导的 CD47 反式激活促进透明细胞肾细胞癌的免疫逃逸。

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202404200
Liu Zhengfang, Zhao Xiumei, Zang Maolin, Yuan Huiyang, Qin Xin, Li Xiaofeng, Zhao Shuo, Tan Ruirong, Yan Keqiang, Liu Li, Fan Yidong, Zhang Ning, Shi Benkang, Han Bo, Chen Shouzhen
细胞生物学
T细胞
CD4
EBP
CD47
EBP1
SMYD3
发表日期：2025
文献求助 收藏

CAMK1D activates AMPK/PINK1/Parkin-dependent mitophagy to promote enzalutamide resistance in prostate cancer

CAMK1D激活AMPK/PINK1/Parkin依赖性线粒体自噬，从而促进前列腺癌对恩扎卢胺的耐药性

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-025-08342-0
Sun, Feifei; Qu, Ying; Mei, Shuyu; Zhang, Lin; Shao, Xianhao; Wang, Xinpei; Liu, Shijia; Wang, Meng; Liu, Wenyao; Yang, Muyi; Hu, Jing; Shi, Benkang; Gao, Lin; Han, Bo
PINK1
肿瘤
肿瘤免疫
NK1
线粒体
Parkin
AMPK
前列腺癌
自噬
发表日期：2025
文献求助 收藏

A randomized, open-label, multi-center, active-controlled phase II study comparing abiraterone acetate tablets (II), an improved formulation, versus originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer

一项随机、开放标签、多中心、活性对照的II期研究，比较改良制剂醋酸阿比特龙片（II）与原研醋酸阿比特龙在转移性去势抵抗性前列腺癌患者中的疗效。

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-025-04053-7
Lu, Xiaolin; Dai, Tao; Chen, Xue; Wu, Bin; Chen, Hui; Wu, Jitao; Yu, Dexin; Ge, Huixin; Li, Jian; Huang, Houbao; Fan, Tiwu; Cheng, Linzhong; Zhang, Xiaoping; Zhang, Xuepei; Yao, Xin; Wei, Junli; Xu, Zhenqiang; Yang, Wenzeng; He, Chaohong; Luo, Jiexin; Guan, Ling; Fu, Bin; Wang, Qilin; Chen, Xiaofeng; Zhang, Yongdong; Shi, Benkang; Zheng, Bin; Wang, Yong; Luo, Hong; Chen, Guoqiang; Wang, Huan; Wang, Quanren; Ye, Dingwei
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Prognostic and predictive role of circulating tumor DNA detection in patients with muscle invasive bladder cancer: a systematic review and meta-analysis

循环肿瘤DNA检测在肌层浸润性膀胱癌患者中的预后和预测作用：系统评价和荟萃分析

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-03707-z
Gao, Xindong; Qi, Wenqiang; Li, Junxian; Xia, Yangyang; Ding, Pengzhong; Guo, Dongyue; Shi, Benkang; Jiang, Xuewen
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Single-cell analysis reveals an important role of CD137L+ macrophages in the host response to uropathogenic Escherichia coli infection in the bladder

单细胞分析揭示了CD137L+巨噬细胞在宿主对膀胱致病性大肠杆菌感染的反应中发挥的重要作用

期刊:PLoS Pathogens
影响因子:5.5
doi:10.1371/journal.ppat.1013543
Yaxiao Liu ，Zizhuo Yang ，Yinrui Xiang ，Guangzhou Cheng ，Lipeng Chen ，Shuai Wang ，Maolin Zang ，Nan Zhou ，Xiaoyi Zhang ，Rui Chen ，Benkang Shi ，Yan Li
单细胞
巨噬细胞
发表日期：2025
文献求助 收藏

Identification of FADS2 as a Contributor of Ferroptosis Escape in Bladder Cancer.

FADS2 在膀胱癌中铁死亡逃逸的发现

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.2
doi:10.1111/jcmm.70710
Li Peixin, Yao Shengwen, Qi Wenqiang, Liu Hanwen, Zhang Xiaoyi, Zhou Bin, Zhang Shijie, Zhang Yaozhong, Liang Hao, Huang Huangwei, Zhao Yihao, Shi Benkang, Chen Jun, Liu Jingchao
肿瘤
膀胱癌
铁死亡
发表日期：2025
文献求助 收藏